Avi Ashkenazi
- Immunology top 0.1%
- Phagocytosis and Immune Regulation 21
- Cancer Research top 0.1%
- NF-κB Signaling Pathways 18
- Molecular Biology top 0.05%
- Cell death mechanisms and regulation 65
- RNA Interference and Gene Delivery 19
- Oncology top 0.2%
- Cell Biology top 0.2%
- Endoplasmic Reticulum Stress and Disease 18
-
- Migraine and Headache Studies 41
-
- Sympathectomy and Hyperhidrosis Treatments 25
-
- Trigeminal Neuralgia and Treatments 20
- Co-authors
- Vishva M. DixitScot A. MarstersRobert PittiDavid A. LawrenceDaniel J. CaponJ. RamachandranHeidi LeblancJohn Winslow
- Partner nations
- United StatesFranceIsrael
In The Last Decade
Avi Ashkenazi
198 papers receiving 32.5k citations
Hit Papers
Peers
Comparison fields: 5 of 161
- Immunology 9.3k
- Cancer Research 5.7k
- Molecular Biology 23.8k
- Oncology 6.0k
- Cell Biology 2.6k
Countries citing papers authored by Avi Ashkenazi
This map shows the geographic impact of Avi Ashkenazi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Avi Ashkenazi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Avi Ashkenazi more than expected).
Fields of papers citing papers by Avi Ashkenazi
This network shows the impact of papers produced by Avi Ashkenazi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Avi Ashkenazi. The network helps show where Avi Ashkenazi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Avi Ashkenazi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 29 | |
| 3 | 2024 | 7 | |
| 4 | 2023 | 5 | |
| 5 | 2022 | 28 | |
| 6 | 2022 | 40 | |
| 7 | 2021 | 26 | |
| 8 | 2021 | 41 | |
| 9 | 2020 | 30 | |
| 10 | 2020 | 88 | |
| 11 | 2015 | 6 | |
| 12 | 2014 | 20 | |
| 13 | Opposing unfolded-protein-response signals converge on death receptor 5 to control apoptosisbreakdown → | 2014 | 447 |
| 14 | 2012 | 72 | |
| 15 | 2010 | 33 | |
| 16 | 2008 | 347 | |
| 17 | 2001 | 167 | |
| 18 | Antibody fusion proteins | 1999 | 30 |
| 19 | 1996 | 119 | |
| 20 | 1995 | 35 |
About Avi Ashkenazi
Avi Ashkenazi is a scholar working on Immunology, Psychiatry and Mental health and Cell Biology, having authored 200 papers that have together received 33.2k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (65 papers), Migraine and Headache Studies (41 papers), Sympathectomy and Hyperhidrosis Treatments (25 papers), Phagocytosis and Immune Regulation (21 papers), Trigeminal Neuralgia and Treatments (20 papers), RNA Interference and Gene Delivery (19 papers), Endoplasmic Reticulum Stress and Disease (18 papers) and NF-κB Signaling Pathways (18 papers). The work is most often cited by research in Immunology (9.3k citations), Cancer Research (5.7k citations) and Molecular Biology (23.8k citations). Avi Ashkenazi has collaborated with scholars based in United States, France and Israel. Frequent co-authors include Vishva M. Dixit, Scot A. Marsters, Robert Pitti, David A. Lawrence, Daniel J. Capon, J. Ramachandran, Heidi Leblanc, John Winslow, Eugene Varfolomeev and Christopher J. Donahue. Their work appears in journals such as Nature, Science and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.